Joint-stock company Grindeks informs that it has established a new anti-cancer final dosage forms’ manufacturing unit, in which 400 thousand lats have been invested. Production...
JSC Grindeks informs that the company successfully continues registration of Mildronate® in the People’s Republic of China. Last week in China, Beijing Grindeks management representatives...
JSC Grindeks informs that, reviewing the Group’s further development, manufacturing plant establishment in Russia is being considered as one of the options. No decisions have...
On 9 December 2010 in the contest “Export and Innovation Award 2010” organized by the Ministry of Economics of the Republic of Latvia and Investment...
Referring to the information, published at the news portal BNS, JSC Grindeks confirms that expansion of cooperation with the Latvian Institute of Organic Synthesis is...
From October 5 to 7, JSC Grindeks will participate in the international exhibition “CPhI Worldwide 2010” in Paris Nord Villepinte, France. During the exhibition Grindeks...
